tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MLYS Stock Latest News

3 Best Stocks to Buy Now, 5/27/2025, According to Top Analysts
Market News3 Best Stocks to Buy Now, 5/27/2025, According to Top Analysts
14d ago
UAL
AKRO
Buy Rating for Mineralys Therapeutics: Strong Clinical Results and Growth Prospects Highlight Significant Upside Potential
PremiumRatings
Buy Rating for Mineralys Therapeutics: Strong Clinical Results and Growth Prospects Highlight Significant Upside Potential
15d ago
MLYS
Mineralys announces late-breaking presentation of data from Launch-HTN trial
PremiumThe Fly
Mineralys announces late-breaking presentation of data from Launch-HTN trial
15d ago
MLYS
Mineralys Therapeutics Approves Key Proposals at Annual Meeting
PremiumCompany Announcements
Mineralys Therapeutics Approves Key Proposals at Annual Meeting
19d ago
8K
MLYS
Mineralys Therapeutics’ Earnings Call: Positive Outlook Amid Challenges
PremiumCompany Announcements
Mineralys Therapeutics’ Earnings Call: Positive Outlook Amid Challenges
26d ago
MLYS
Mineralys Therapeutics price target lowered to $48 from $52 at Guggenheim
PremiumThe FlyMineralys Therapeutics price target lowered to $48 from $52 at Guggenheim
27d ago
MLYS
3 Best Stocks to Buy Now, 5/14/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 5/14/2025, According to Top Analysts
27d ago
APP
MLYS
Strong Financial Position and Promising Clinical Results Support Buy Rating for Mineralys Therapeutics
Premium
Ratings
Strong Financial Position and Promising Clinical Results Support Buy Rating for Mineralys Therapeutics
28d ago
MLYS
Positive Buy Rating for Lorundrostat Driven by Successful Trials and Future Potential
PremiumRatings
Positive Buy Rating for Lorundrostat Driven by Successful Trials and Future Potential
28d ago
MLYS
Optimistic Buy Rating for Mineralys Therapeutics Driven by Strategic Developments and Upcoming Data Releases
PremiumRatings
Optimistic Buy Rating for Mineralys Therapeutics Driven by Strategic Developments and Upcoming Data Releases
28d ago
MLYS
Mineralys Therapeutics Reports Strong Trial Results and Financial Growth
PremiumCompany Announcements
Mineralys Therapeutics Reports Strong Trial Results and Financial Growth
29d ago
MLYS
Mineralys Therapeutics reports Q1 EPS (79c), consensus (98c)
PremiumThe Fly
Mineralys Therapeutics reports Q1 EPS (79c), consensus (98c)
29d ago
MLYS
Mineralys Therapeutics, Inc. (MLYS) Q1 Earnings Cheat Sheet
PremiumPre-EarningsMineralys Therapeutics, Inc. (MLYS) Q1 Earnings Cheat Sheet
1M ago
MLYS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
NVS
ABEO
Mineralys Therapeutics’ lorundrostat shows efficacy in NEJM-published study
Premium
The Fly
Mineralys Therapeutics’ lorundrostat shows efficacy in NEJM-published study
2M ago
MLYS
Buy Rating Affirmed for Lorundrostat Amid Positive Trial Results and Market Potential
PremiumRatings
Buy Rating Affirmed for Lorundrostat Amid Positive Trial Results and Market Potential
2M ago
MLYS
Mineralys Therapeutics price target raised to $42 from $30 at H.C. Wainwright
PremiumThe Fly
Mineralys Therapeutics price target raised to $42 from $30 at H.C. Wainwright
2M ago
MLYS
3 Best Stocks to Buy Now, 4/1/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 4/1/2025, According to Top Analysts
2M ago
DAVE
ENVX
Mineralys Therapeutics Unveils Promising Trial Results for Lorundrostat
PremiumCompany Announcements
Mineralys Therapeutics Unveils Promising Trial Results for Lorundrostat
2M ago
8K
MLYS
3 Best Stocks to Buy Now, 3/31/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 3/31/2025, According to Top Analysts
2M ago
TLN
BRZE
Mineralys Therapeutics presents results from Phase 2 Advance-HTN trial
Premium
The Fly
Mineralys Therapeutics presents results from Phase 2 Advance-HTN trial
2M ago
MLYS
Promising Clinical Trial Results and Safety Profile of Lorundrostat Support Buy Rating for Mineralys Therapeutics
Premium
Ratings
Promising Clinical Trial Results and Safety Profile of Lorundrostat Support Buy Rating for Mineralys Therapeutics
2M ago
MLYS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >